The role of omalizumab or rhuMAB-E25 in the treatment of allergic rhinitis
- PMID: 15332407
- DOI: 10.1183/09031936.04.00031604
The role of omalizumab or rhuMAB-E25 in the treatment of allergic rhinitis
Comment on
-
Omalizumab inhibits allergen challenge-induced nasal response.Eur Respir J. 2004 Mar;23(3):414-8. doi: 10.1183/09031936.04.00024504. Eur Respir J. 2004. PMID: 15065831 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical